Pheochromocytoma (PHEO) and Paraganglioma (PGL)
This book outlines some new advances in genetics, clinical evaluation, localization, therapy (newly including immunotherapy) of pheochromocytoma and paraganglioma including their metastatic counterparts. Well-known and experienced clinicians and scientists contributed to this book to include some no...
Saved in:
| : | |
|---|---|
| Year of Publication: | 2019 |
| Language: | English |
| Physical Description: | 1 electronic resource (380 p.) |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| LEADER | 05185nam-a2201561z--4500 | ||
|---|---|---|---|
| 001 | 993548163504498 | ||
| 005 | 20231214133452.0 | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 202102s2019 xx |||||o ||| 0|eng d | ||
| 020 | |a 3-03921-655-4 | ||
| 035 | |a (CKB)4100000010106278 | ||
| 035 | |a (oapen)https://directory.doabooks.org/handle/20.500.12854/56155 | ||
| 035 | |a (EXLCZ)994100000010106278 | ||
| 041 | 0 | |a eng | |
| 100 | 1 | |a Pacak, Karel |4 auth | |
| 245 | 1 | 0 | |a Pheochromocytoma (PHEO) and Paraganglioma (PGL) |
| 246 | |a Pheochromocytoma | ||
| 260 | |b MDPI - Multidisciplinary Digital Publishing Institute |c 2019 | ||
| 300 | |a 1 electronic resource (380 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 520 | |a This book outlines some new advances in genetics, clinical evaluation, localization, therapy (newly including immunotherapy) of pheochromocytoma and paraganglioma including their metastatic counterparts. Well-known and experienced clinicians and scientists contributed to this book to include some novel approaches to these tumors. This book will serve to various health care professionals from different subspecialties, but mainly oncologists, endocrinologists, endocrine surgeons, pediatricians, and radiologists. This book shows that the field of pheochromocytoma/paraganglioma is evolving and a significant progress has been made in last 5 years requiring that health care professionals and scientists will learns new information and implement it in their clinical practice or scientific work, respectively. This book should not be missed by anybody who is focusing on neuroendocrine tumors, their newest evaluation and treatment. | ||
| 546 | |a English | ||
| 653 | |a polycythemia | ||
| 653 | |a peptide receptor radiotherapy | ||
| 653 | |a vasculogenesis | ||
| 653 | |a catecholamines | ||
| 653 | |a neuroendocrine | ||
| 653 | |a GTV | ||
| 653 | |a adaptive immunity | ||
| 653 | |a therapy resistance | ||
| 653 | |a histology | ||
| 653 | |a transgenic mice | ||
| 653 | |a cryoablation | ||
| 653 | |a spheroids | ||
| 653 | |a energy metabolism | ||
| 653 | |a somatostatinoma | ||
| 653 | |a angiogenesis | ||
| 653 | |a pheochromocytoma | ||
| 653 | |a SDHD | ||
| 653 | |a percutaneous ethanol injection | ||
| 653 | |a metanephrines | ||
| 653 | |a SDHB | ||
| 653 | |a global longitudinal strain | ||
| 653 | |a mutation | ||
| 653 | |a normetanephrines | ||
| 653 | |a catecholamine | ||
| 653 | |a PASS | ||
| 653 | |a PGL | ||
| 653 | |a 177Lu-DOTATATE | ||
| 653 | |a chromosomal alteration | ||
| 653 | |a speckle-tracking echocardiography | ||
| 653 | |a lL-6 | ||
| 653 | |a dog | ||
| 653 | |a percutaneous ablation | ||
| 653 | |a stem-like tumor cells | ||
| 653 | |a EPAS1 | ||
| 653 | |a neural crest | ||
| 653 | |a fluorescence imaging | ||
| 653 | |a neutrophil | ||
| 653 | |a xenograft | ||
| 653 | |a inflammation | ||
| 653 | |a head and neck | ||
| 653 | |a weighted standard deviation | ||
| 653 | |a FGF21 | ||
| 653 | |a calorimetry | ||
| 653 | |a HIF | ||
| 653 | |a average real variability | ||
| 653 | |a next-generation sequencing | ||
| 653 | |a adrenocortical carcinoma | ||
| 653 | |a carotid body | ||
| 653 | |a hypoxia-inducible factor | ||
| 653 | |a paraganglioma | ||
| 653 | |a succinate dehydrogenase | ||
| 653 | |a blood pressure variability | ||
| 653 | |a arrhythmia | ||
| 653 | |a mortality | ||
| 653 | |a NF1 | ||
| 653 | |a toll-like receptor | ||
| 653 | |a GAPP | ||
| 653 | |a NET | ||
| 653 | |a subclinical systolic dysfunction | ||
| 653 | |a pheochromocytoma and paraganglioma | ||
| 653 | |a PET-CT | ||
| 653 | |a pan-cancer analysis | ||
| 653 | |a mouse pheochromocytoma cells | ||
| 653 | |a innate immunity | ||
| 653 | |a neurogenesis | ||
| 653 | |a neuroendocrine tumor | ||
| 653 | |a obesity | ||
| 653 | |a hypotension | ||
| 653 | |a hypoxia | ||
| 653 | |a CNV detection | ||
| 653 | |a 18F-FDOPA | ||
| 653 | |a comparative genomics | ||
| 653 | |a adrenomedullary function | ||
| 653 | |a PCC | ||
| 653 | |a pathogen-associated molecular patterns | ||
| 653 | |a adrenal tumor | ||
| 653 | |a radiotherapy | ||
| 653 | |a 11C-hydroxy-ephedrine | ||
| 653 | |a radiofrequency ablation | ||
| 653 | |a PPGL | ||
| 653 | |a minimally invasive procedure | ||
| 653 | |a sporadic | ||
| 653 | |a diabetes mellitus | ||
| 653 | |a adrenal incidentaloma | ||
| 653 | |a germline mutation | ||
| 653 | |a immunotherapy | ||
| 653 | |a VHL | ||
| 653 | |a immunohistochemistry | ||
| 653 | |a metastatic OR malignant pheochromocytoma | ||
| 653 | |a erythropoietin | ||
| 653 | |a postoperative | ||
| 653 | |a targeted therapy | ||
| 653 | |a PRRT | ||
| 653 | |a metastatic | ||
| 653 | |a mitochondria | ||
| 653 | |a T cell | ||
| 653 | |a TCA cycle | ||
| 653 | |a meta-analysis | ||
| 653 | |a pseudohypoxia | ||
| 653 | |a ectopic secretion | ||
| 653 | |a radiosensitization | ||
| 653 | |a chromogranin A | ||
| 653 | |a hereditary | ||
| 653 | |a hypertension | ||
| 653 | |a PET | ||
| 653 | |a phosphorylation tyrosine hydroxylase | ||
| 776 | |z 3-03921-654-6 | ||
| 700 | 1 | |a Taïeb, David |4 auth | |
| 906 | |a BOOK | ||
| ADM | |b 2023-12-15 05:54:56 Europe/Vienna |f system |c marc21 |a 2020-02-01 22:26:53 Europe/Vienna |g false | ||
| AVE | |i DOAB Directory of Open Access Books |P DOAB Directory of Open Access Books |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338741640004498&Force_direct=true |Z 5338741640004498 |b Available |8 5338741640004498 | ||